STEVEN DANIEL: Open Payments
NPI 1063189884 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 41 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $458 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 7 | $135 |
| Amgen Inc. | 5 | $73 |
| Lilly USA, LLC | 4 | $62 |
| ABBVIE INC. | 3 | $59 |
| Exact Sciences Corporation | 3 | $53 |
| ViiV Healthcare Company | 2 | $46 |
| Madrigal Pharmaceuticals | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Inspire Medical Systems, Inc. | 2 | $38 |
| Eisai Inc. | 1 | $34 |
Products named: Dexcom G6 Transmitter, MOUNJARO, QULIPTA, EVENITY, Cologuard Collection Kit, APRETUDE, REZDIFFRA, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
